Deborah Birx, a director of Theravance, just received 10,748 restricted shares from the company. The restricted shares don't become available to Birx until such time as they become vested. Birx now owns at least 10,748 restricted shares of the company.
Some additional info was provided as follows:
Each restricted stock unit represents the right to receive, following vesting, one share of Common Stock.
One-half of the restricted stock units will vest on March 9, 2022, and the remainder will vest on March 9, 2023.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To rec eive a free e-mail notification whenever Theravance makes a similar move, sign up!